Complementary treatment and markers in inflammatory bowel diseases

dc.contributor.authorPagoldh, Maria
dc.date.accessioned2014-01-31T07:24:38Z
dc.date.available2014-01-31T07:24:38Z
dc.date.issued2014-01-31
dc.description.abstractComplementary Treatment and Markers in Inflammatory Bowel Diseases Maria Pagoldh Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden Aims: The aims of this thesis were to evaluate potential prognostic markers and addition of complementary treatments in inflammatory bowel diseases. Background: Inflammatory bowel diseases, the two main types of which are ulcerative colitis and Crohn’s disease, affect nearly 1% of the Scandinavian population and implies a risk of a chronic progressive, disabling disease. When considering treatment options, issues are: pre-dicting short and long-term prognosis, selecting optimal treatment options and providing ap-propriate care for complications of the conditions or treatments. Methods: Selected variables were investigated to determine their ability to predict colectomy in an early phase of a severe attack of ulcerative colitis in patients admitted to hospital. Hy-perbaric oxygen treatment was tested as a complementary treatment in acute severe ulcerative colitis. Addition of supplementary treatment with cereals was evaluated in patients with se-quelae after intestinal resections. Results and Conclusions: Analyses of stool frequency, faecal weight and complement factor 3c in plasma may contribute to an early prediction of the disease course in a severe attack of ulcerative colitis. Hyperbaric oxygen treatment as a complementary treatment in a severe at-tack of ulcerative colitis does not improve clinical outcome. Specially processed cereals, as well as non-processed cereals, can be safely used in patients with previous intestinal resec-tions. Intake of non-processed cereals may decrease faecal volume in these patients. Key words: inflammatory bowel diseases, ulcerative colitis, Crohn disease, predictor, com-plementary therapies, hyperbaric oxygen therapy ISBN: 978-91-628-8844-2 http://hdl.handle.net/2077/34071 Gothenburg 2014sv
dc.gup.defencedate2014-02-21
dc.gup.defenceplaceFredagen den 21 februari 2014, kl 13.00, Aulan, Centralkliniken Sahlgrenska Universitetssjukhuset/Östra sjukhusetsv
dc.gup.departmentInstitute of Medicine. Department of Molecular and Clinical Medicinesv
dc.gup.dissdb-fakultetSA
dc.gup.mailmaria.pagoldh@vgregion.sesv
dc.gup.originUniversity of Gothenburg. Sahlgrenska Academysv
dc.identifier.isbn978-91-628-8845-9
dc.identifier.urihttp://hdl.handle.net/2077/34071
dc.language.isoengsv
dc.relation.haspartI. Pagoldh M et al. Faecal analysis and plasma complement factor 3c levels at admissionfor an acute attack of ulcerative colistis are predictive of the need for colectomy. Eur J Gastroenterol Hepatol. 2014 Jan 13. [Epub ahead of print] ::PMID::24418832sv
dc.relation.haspartII. Pagoldh M et al. Hyperbaric oxygen therapy does not improve the effects of standardized treatment in a severe attack of ulcerative colitis: a prospective randomized study. Scand J Gastroenterol 2013;48(9):1033-1040. Epub Jul 23. ::doi::10.3109/00365521.2013.819443sv
dc.relation.haspartIII. Pagoldh M et al. Effects of a supplementary diet with specially processed cereals in patients with short bowel syndrome. Eur J Gastroenterol Hepatol 2008;20:(11)1085-1093. ::doi::10.1097/MEG.0b013e328303c00asv
dc.subjectinflammatory bowel diseasessv
dc.subjectulcerative colitissv
dc.subjectCrohn diseasesv
dc.subjectpredictorsv
dc.subjectcomplementary therapiessv
dc.subjecthyperbaric oxygen therapysv
dc.titleComplementary treatment and markers in inflammatory bowel diseasessv
dc.typetexteng
dc.type.degreeDoctor of Philosophy (Medicine)sv
dc.type.svepDoctoral thesiseng

Files

Original bundle

Now showing 1 - 3 of 3
No Thumbnail Available
Name:
gupea_2077_34071_1.pdf
Size:
150 KB
Format:
Adobe Portable Document Format
Description:
Cover
No Thumbnail Available
Name:
gupea_2077_34071_2.pdf
Size:
850.48 KB
Format:
Adobe Portable Document Format
Description:
Thesis frame
No Thumbnail Available
Name:
gupea_2077_34071_3.pdf
Size:
120.17 KB
Format:
Adobe Portable Document Format
Description:
Abstract

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.68 KB
Format:
Item-specific license agreed upon to submission
Description: